Targeted Capture and Heterologous Expression of the Pseudoalteromonas Alterochromide Gene Cluster in Escherichia coli Represents a Promising Natural Product Exploratory Platform

Marine pseudoalteromonads represent a very promising source of biologically important natural product molecules. To access and exploit the full chemical capacity of these cosmopolitan Gram-(−) bacteria, we sought to apply universal synthetic biology tools to capture, refactor, and express biosynthetic gene clusters for the production of complex organic compounds in reliable host organisms. Here, we report a platform for the capture of proteobacterial gene clusters using a transformation-associated recombination (TAR) strategy coupled with direct pathway manipulation and expression in Escherichia coli. The ∼34 kb pathway for production of alterochromide lipopeptides by Pseudoalteromonas piscicida JCM 20779 was captured and heterologously expressed in E. coli utilizing native and E. coli-based T7 promoter sequences. Our approach enabled both facile production of the alterochromides and in vivo interrogation of gene function associated with alterochromide’s unusual brominated lipid side chain. This platform represents a simple but effective strategy for the discovery and biosynthetic characterization of natural products from marine proteobacteria.

[1]  P. Neubauer,et al.  Reconstituted biosynthesis of the nonribosomal macrolactone antibiotic valinomycin in Escherichia coli. , 2014, ACS synthetic biology.

[2]  Roger G. Linington,et al.  Insights into Secondary Metabolism from a Global Analysis of Prokaryotic Biosynthetic Gene Clusters , 2014, Cell.

[3]  V. Paul,et al.  The chemical cue tetrabromopyrrole from a biofilm bacterium induces settlement of multiple Caribbean corals , 2014, Proceedings of the Royal Society B: Biological Sciences.

[4]  M. Schorn,et al.  Biosynthesis of polybrominated aromatic organic compounds by marine bacteria , 2014, Nature chemical biology.

[5]  P. Dorrestein,et al.  Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A , 2014, Proceedings of the National Academy of Sciences.

[6]  Christopher M Thomas,et al.  Biosynthesis of thiomarinol A and related metabolites of Pseudoalteromonas sp SANK 73390 , 2014 .

[7]  Joseph P Noel,et al.  The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life. , 2014, Natural product reports.

[8]  Brian O. Bachmann,et al.  Microbial genome mining for accelerated natural products discovery: is a renaissance in the making? , 2014, Journal of Industrial Microbiology & Biotechnology.

[9]  Gregory L. Challis,et al.  Exploitation of the Streptomyces coelicolor A3(2) genome sequence for discovery of new natural products and biosynthetic pathways , 2014, Journal of Industrial Microbiology & Biotechnology.

[10]  Rolf Müller,et al.  Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. , 2013, Natural product reports.

[11]  M. Wietz,et al.  Antagonistic Interactions Mediated by Marine Bacteria: The Role of Small Molecules , 2013, Journal of Chemical Ecology.

[12]  Nuno Bandeira,et al.  MS/MS networking guided analysis of molecule and gene cluster families , 2013, Proceedings of the National Academy of Sciences.

[13]  Sarah E Ongley,et al.  High-titer heterologous production in E. coli of lyngbyatoxin, a protein kinase C activator from an uncultured marine cyanobacterium. , 2013, ACS chemical biology.

[14]  Kai Blin,et al.  antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producers , 2013, Nucleic Acids Res..

[15]  Christopher T Walsh,et al.  Flavoenzymes: versatile catalysts in biosynthetic pathways. , 2013, Natural product reports.

[16]  Nuno Bandeira,et al.  Mass spectral molecular networking of living microbial colonies , 2012, Proceedings of the National Academy of Sciences.

[17]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[18]  K. Enomoto,et al.  Characterization of a gene cluster and its putative promoter region for violacein biosynthesis in Pseudoalteromonas sp. 520P1 , 2011, Applied Microbiology and Biotechnology.

[19]  J. Vederas,et al.  [Drug discovery and natural products: end of era or an endless frontier?]. , 2011, Biomeditsinskaia khimiia.

[20]  L. Gram,et al.  Bioactivity, Chemical Profiling, and 16S rRNA-Based Phylogeny of Pseudoalteromonas Strains Collected on a Global Research Cruise , 2011, Marine Biotechnology.

[21]  Amy L. Lane,et al.  A sea of biosynthesis: marine natural products meet the molecular age. , 2011, Natural product reports.

[22]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[23]  Haoran Zhang,et al.  Methods and options for the heterologous production of complex natural products. , 2011, Natural product reports.

[24]  B. Moore,et al.  Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics. , 2010, Angewandte Chemie.

[25]  J. Clardy,et al.  Discovery of 3-Formyl-Tyrosine Metabolites from Pseudoalteromonas tunicata through Heterologous Expression , 2009, Journal of the American Chemical Society.

[26]  F. Azam,et al.  Antagonistic interactions among coral-associated bacteria. , 2010, Environmental microbiology.

[27]  Haruo Ikeda,et al.  Genomic basis for natural product biosynthetic diversity in the actinomycetes. , 2009, Natural product reports.

[28]  Vladimir Larionov,et al.  Selective isolation of genomic loci from complex genomes by transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae , 2008, Nature Protocols.

[29]  E. Ivanova,et al.  “Pseudoalteromonas januaria” SUT 11 as the Source of Rare Lipodepsipeptides , 2008, Current Microbiology.

[30]  J. Bowman Bioactive Compound Synthetic Capacity and Ecological Significance of Marine Bacterial Genus Pseudoalteromonas , 2007, Marine drugs.

[31]  S. Kjelleberg,et al.  Molecular investigation of the distribution, abundance and diversity of the genus Pseudoalteromonas in marine samples. , 2007, FEMS microbiology ecology.

[32]  H. Laatsch,et al.  Bromoalterochromides A and A′, Unprecedented Chromopeptides from a Marine Pseudoalteromonas maricaloris Strain KMM 636T† , 2007, The Journal of Antibiotics.

[33]  M. Bowman,et al.  Structural determinants and modulation of substrate specificity in phenylalanine-tyrosine ammonia-lyases. , 2006, Chemistry & biology.

[34]  Paul R Jensen,et al.  Developing a new resource for drug discovery: marine actinomycete bacteria , 2006, Nature chemical biology.

[35]  Clay C C Wang,et al.  Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli , 2006, Nature chemical biology.

[36]  G. B. Elyakov,et al.  Controlling production of brominated cyclic depsipeptides by Pseudoalteromonas maricaloris KMM 636T , 2005, Letters in applied microbiology.

[37]  S. Kjelleberg,et al.  Competitive Interactions in Mixed-Species Biofilms Containing the Marine Bacterium Pseudoalteromonas tunicata , 2005, Applied and Environmental Microbiology.

[38]  M. Tutino,et al.  Exocellular Peptides from Antarctic PsychrophilePseudoalteromonas Haloplanktis , 2005, Marine Biotechnology.